Non-Viral Transfection Reagents market Professional Survey Report by 2035
Given the increasing focus on genetically modified therapies, there is a consequent rise in the demand for efficient gene delivery vectors; in recent years, innovators are actively evaluating the potential of non-viral transfection agents.
Therefore, driven by the growing demand for cell and gene therapies, and the active ongoing efforts of industry stakeholders, the non-viral transfection reagents and systems market is anticipated to grow at a steady pace in the foreseen future.
The future opportunity within the non-viral transfection reagents and systems market has been analyzed across the following segments:
Non-Viral Based Transfection Methods
Chemical-based Methods
Physical-based Methods
Other Methods
End-Users
Academic And Research Institutions
Stem Pharmaceutical Companies
Other End-Users
Area of Application
Clinical Applications
Research Applications
Key Geographical Regions
North America
Europe
Asia-Pacific
Rest of the World (RoW)
The “Non-Viral Transfection Reagents and Systems Market (2nd Edition), 2023-2035” report features the following companies, which we identified to be key players in this domain:
BEX
Bio-Rad Laboratories
BTX
Celsion Corporation
Genprex
Inovio Pharmaceuticals
MaxCyte
MilliporeSigma
NepaGene
OZ Biosciences
Thermo Fisher Scientific
Table of Contents
1. Preface
2. Executive Summary
3. Introduction
4. Non-Viral Transfection Reagents: Market Landscape
5. Electroporation-Based Transfection Systems: Market Landscape
6. Other Non-Viral Transfection Systems: Market Landscape
7. Company Competitiveness Analysis
8. Technology Competitiveness Analysis
9. Company Profiles
10. Potential Strategic Partners
11. Big Pharma Initiatives
12. Patent Analysis
13. Publication Analysis
14. Roots Analysis Pricing Strategy Framework
15. Market Sizing and Opportunity Analysis
16. Executive Insights
17. Conclusion
18. Appendix 1: Tabulated Data
19. Appendix 2: List of Companies and Organizations
To view more details on this report, click on the link:
https://www.rootsanalysis.com/....reports/view_documen
Learn from experts: do you know about these emerging industry trends?
Long-Acting Drug Delivery: A Novel Pharmacological Strategy to Deliver Therapeutic Modalities
Digital Therapies: The “Digital Pills” of current generation
About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.
Learn more about Roots Analysis consulting services:
Roots Analysis Consulting - the preferred research partner for global firms
Contact:
Ben Johnson
+1 (415) 800 3415
Ben.johnson@rootsanalysis.com
To view more details on this report, click on the link:
https://www.rootsanalysis.com/....reports/view_documen
